- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06579742
A Clinical Trial to Examine the Efficacy of a Supplement to Support Healthy Hair and Skin
August 29, 2024 updated by: Scale Media Inc
This is a triple-blinded, randomized, placebo-controlled clinical trial designed to evaluate the efficacy of Scale Media's Live Conscious Beyond Collagen supplement on overall hair and skin health.
The study will involve 50 male or female participants aged 40 and over who have self-perceived hair thinning and shedding.
The trial will last for 24 weeks and includes the completion of questionnaires and photo submissions at specific time points.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Santa Monica, California, United States, 90404
- Citruslabs
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Female or male
- Self-perceived hair thinning, specifically on the top and crown of the scalp for at least three months
- Self-perceived increased hair shedding for at least three months
- Concerns regarding skin health and appearance
- Has been using the same hair care routine and products for at least one month prior to the study, i.e., shampoo, conditioner, and products
- Has been using the same skincare routine and products for at least one month prior to the study, i.e., moisturizer, serums, etc.
- Willing to maintain the same hair care routine and products throughout the study
- Willing to maintain the same skincare routine and products throughout the study
- Willing to maintain the same diet and exercise regimen during the study
- Willing to refrain from taking any vitamins, minerals, or herbal supplements that target hair growth or skin health during the study
- Willing to refrain from taking any new vitamins, minerals, or supplements of any kind during the study
- Willing to avoid introducing any new prescription medications or supplements that target hair health and appearance of skin health and appearance during the study
- Be generally healthy and do not live with any uncontrolled chronic disease
- Willing to stop taking any other multivitamin supplements at least one month prior to and for the entire study duration
- Willing to avoid dyeing the hair for the duration of the study
- Living with someone who can take their study photos for the duration of the study
Exclusion Criteria:
- Anyone with a diagnosed hair loss or hair thinning health condition, except for female pattern baldness (e.g., alopecia areata)
- Women who are pregnant, breastfeeding, or trying to conceive
- Anyone currently taking iron supplements
- Anyone unwilling or unable to follow the study protocol
- Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
- Anyone who does not consume animal products for personal or religious reasons
- Is undergoing or planning to undergo laboratory testing and/or significant medical procedures during the study duration
- A history of severe allergic reactions, including but not limited to any of the product's ingredients
- Has undergone any chemical treatments to the hair in the last three months, e.g., chemical straightening, hair extensions with chemical bonding, perms, and relaxers
- Has any planned chemical treatments for the hair during the study period, e.g., chemical straightening, hair extensions with chemical bonding, perms, and relaxers
- Has any planned cosmetic treatments to the face, including botox, dermal filler, chemical peels, etc.
- Currently undergoing hair loss treatment, including mechanical scalp stimulation, or has done so in the last three months
- Currently using other hair growth/thickening products
- Currently taking any prescription medication for hair loss, or has done so in the last three months
- Currently taking any prescription medication for skin health, or has done so in the last three months
- Has undergone any surgeries or invasive treatments in the last six months
- Has had any major illness in the last three months
- Currently taking medication that has hair loss as a known or observed side effect
- Currently undergoing or have you recently undergone chemotherapy or radiotherapy
- Anyone who has had a hair transplant within the last year
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Live Conscious Beyond Collagen Supplement
Participants in this arm will receive the Live Conscious Beyond Collagen supplement.
The supplement contains Vitamin C (90 mg), Biotin (2500 mcg), and a Proprietary Collagen Blend (10.1 g) including Types I & III Bovine Collagen, Type II Marine Collagen, Type II Chicken Sternum Collagen, and Types I, V & X Eggshell Membrane Collagen.
|
Participants in the experimental arm will take 1 scoop (10.4 g) of Live Conscious Beyond Collagen supplement mixed with 12 fl oz of water in the evening after their last meal of the day for 24 weeks.
|
|
Placebo Comparator: Placebo
Participants in this arm will receive a placebo product.
The placebo contains Maltodextrin.
|
Participants in the placebo comparator arm will take 1 scoop (10.4 g) of the placebo product (Maltodextrin) mixed with 12 fl oz of water in the evening after their last meal of the day for 24 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Hair Density and Hair Volume
Time Frame: Baseline, Month 3, and Month 6
|
Hair health will be assessed through expert dermatologist grading and participant questionnaires to measure changes in hair density and hair volume over the course of the study.
|
Baseline, Month 3, and Month 6
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Skin Health (Fine Lines, Wrinkles, Texture, and Elasticity)
Time Frame: Baseline, Month 3, and Month 6
|
Skin health will be evaluated using participant self-reported questionnaires and expert dermatologist grading to assess changes in fine lines, wrinkles, skin texture, elasticity, brightness, radiance, firmness, and roughness over the course of the study.
|
Baseline, Month 3, and Month 6
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 7, 2024
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
December 31, 2024
Study Registration Dates
First Submitted
August 28, 2024
First Submitted That Met QC Criteria
August 29, 2024
First Posted (Actual)
August 30, 2024
Study Record Updates
Last Update Posted (Actual)
August 30, 2024
Last Update Submitted That Met QC Criteria
August 29, 2024
Last Verified
August 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20423
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hair Loss
-
Bionos Biotech S.L.Active, not recruitingFemale Pattern Hair Loss | Hair Loss | Hair CareSpain
-
University of British ColumbiaCompletedFemale Pattern Hair LossCanada
-
Ain Shams UniversityCompletedFemale Pattern Hair LossEgypt
-
HistogenCompleted
-
Sohag UniversityCompleted
-
China Medical University HospitalCompleted
-
Merz Therapeutics GmbHCompletedDiffuse Hair Loss in FemalesGermany
-
Applied Biology, Inc.CompletedAlopecia | Female Pattern Hair LossUnited States, Australia, India, Italy
-
Olistic Research Labs S.L.RecruitingEarly Female Pattern Hair Loss (FPHL)Germany
-
Olistic Research Labs S.L.CompletedEarly Female Pattern Hair Loss (FPHL)Spain